STOCK TITAN

[Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Brian Newman, a director of Colgate-Palmolive Co. (CL), reported a non-derivative acquisition of 228 shares of common stock on 10/01/2025 at a price of $82.13 per share. Following the transaction he directly beneficially owns 5,065 shares and indirectly holds 36 shares through a family trust. The filing identifies the purchase code A(1), and the explanation states this represents a portion of the annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

Brian Newman, un direttore della Colgate-Palmolive Co. (CL), ha riportato una acquisizione non derivativa di 228 azioni ordinarie in data 01/10/2025 a un prezzo di 82,13$ per azione. A seguito della transazione possiede direttamente 5.065 azioni e indirettamente ne detiene 36 tramite un trust familiare. La presentazione identifica il codice d'acquisto A(1), e la spiegazione indica che rappresenta una parte della retribuzione annuale in contanti differita in un conto unità azionaria ai sensi del piano di compensazione differita per i direttori non dipendenti della società. Il Form 4 è stato firmato da un procuratore in loco in data 03/10/2025.

Brian Newman, un director de Colgate-Palmolive Co. (CL), informó una adquisición no derivativa de 228 acciones ordinarias el 01/10/2025 a un precio de $82,13 por acción. Tras la transacción posee directamente 5.065 acciones y indirectamente 36 acciones a través de un fideicomiso familiar. La presentación identifica el código de compra A(1), y la explicación indica que representa una parte de la compensación anual en efectivo diferido en una cuenta de unidades de acciones bajo el Plan de Compensación Diferida para Directores No Empleados de la empresa. El Formulario 4 fue firmado por un apoderado el 03/10/2025.

브라이언 뉴먼Colgate-Palmolive Co. (CL)이사로서 01/10/2025에 주당 $82.13의 가격으로 228주 일반주를 비유래 취득했다고 보고했습니다. 거래 후 그는 직접적으로 5,065주를 보유하고 있으며, 가족 신탁을 통해 간접적으로 36주를 보유합니다. 제출서는 매수 코드 A(1)을 식별하고, 이는 회사의 비직원 이사들을 위한 현금 연간 보수의 일부를 주식단위계좌로 이연하는 Deferred Compensation Plan의 주식단위 계정에 해당함을 설명합니다. Form 4는 2025년 10월 3일에 법무대리인이 서명했습니다.

Brian Newman, un directeur de Colgate-Palmolive Co. (CL), a déclaré une acquisition non dérivée de 228 actions ordinaires le 01/10/2025 à un prix de 82,13 $ par action. Suite à la transaction, il détient directement 5 065 actions et indirectement 36 actions par le biais d'une fiducie familiale. Le dossier identifie le code d'achat A(1), et l'explication indique qu'il représente une partie du salaire annuel en espèces différé dans un compte d'unités d'actions dans le cadre du plan de rémunération différée pour les administrateurs non salariés de l'entreprise. Le Form 4 a été signé par un mandataire le 03/10/2025.

Brian Newman, ein Direktor der Colgate-Palmolive Co. (CL), meldete eine nicht derivativ erworbene Übernahme von 228 Stammaktien am 01.10.2025 zu einem Preis von 82,13 $ pro Aktie. Nach der Transaktion besitzt er direkt 5.065 Aktien und indirekt 36 Aktien durch einen Familientrust. Die Anmeldung identifiziert den Kaufcode A(1), und die Erläuterung besagt, dass dies einen Teil des jährlichen Bargeldentgelts darstellt, das in ein Aktien-Einheitenkonto im Rahmen des Deferred Compensation Plans for Non-Employee Directors des Unternehmens eingezogen wird. Das Formular 4 wurde am 03.10.2025 von einem Bevollmächtigten unterschrieben.

برايان نيمان، مدير في شركة Colgate-Palmolive Co. (CL)، أفاد بعملية اكتساب غير مشتقة لـ 228 سهمًا من الأسهم العادية في تاريخ 01/10/2025 بسعر $82.13 للسهم. بعد الصفقة، يمتلك مباشرة 5,065 سهمًا وبشكل غير مباشر 36 سهمًا من خلال صندوق عائلي. تُحدد الوثيقة رمز الشراء A(1)، وتوضح أن ذلك يمثل جزءًا من الراتب النقدي السنوي المؤجل في حساب وحدات الأسهم وفقًا لخطة التعويض المؤجل لمديري الشركة غير الموظفين. مُنح موقع النموذج 4 من قبل وكيل نيابة في تاريخ 03/10/2025.

Brian Newman,Colgate-Palmolive Co. (CL) 的 董事,报告在 2025/10/01 以每股 $82.13 美元的价格非衍生地取得 228 股普通股。交易后,他直接拥有 5,065 股,并通过一个家族信托间接持有 36 股。提交文件识别购买代码 A(1),说明这代表公司为非雇员董事的延期薪酬计划下的股票单位账户中延发的部分年度现金报酬。Form 4 由代理人在 2025/10/03 签署。

Positive
  • None.
Negative
  • None.

Brian Newman, un direttore della Colgate-Palmolive Co. (CL), ha riportato una acquisizione non derivativa di 228 azioni ordinarie in data 01/10/2025 a un prezzo di 82,13$ per azione. A seguito della transazione possiede direttamente 5.065 azioni e indirettamente ne detiene 36 tramite un trust familiare. La presentazione identifica il codice d'acquisto A(1), e la spiegazione indica che rappresenta una parte della retribuzione annuale in contanti differita in un conto unità azionaria ai sensi del piano di compensazione differita per i direttori non dipendenti della società. Il Form 4 è stato firmato da un procuratore in loco in data 03/10/2025.

Brian Newman, un director de Colgate-Palmolive Co. (CL), informó una adquisición no derivativa de 228 acciones ordinarias el 01/10/2025 a un precio de $82,13 por acción. Tras la transacción posee directamente 5.065 acciones y indirectamente 36 acciones a través de un fideicomiso familiar. La presentación identifica el código de compra A(1), y la explicación indica que representa una parte de la compensación anual en efectivo diferido en una cuenta de unidades de acciones bajo el Plan de Compensación Diferida para Directores No Empleados de la empresa. El Formulario 4 fue firmado por un apoderado el 03/10/2025.

브라이언 뉴먼Colgate-Palmolive Co. (CL)이사로서 01/10/2025에 주당 $82.13의 가격으로 228주 일반주를 비유래 취득했다고 보고했습니다. 거래 후 그는 직접적으로 5,065주를 보유하고 있으며, 가족 신탁을 통해 간접적으로 36주를 보유합니다. 제출서는 매수 코드 A(1)을 식별하고, 이는 회사의 비직원 이사들을 위한 현금 연간 보수의 일부를 주식단위계좌로 이연하는 Deferred Compensation Plan의 주식단위 계정에 해당함을 설명합니다. Form 4는 2025년 10월 3일에 법무대리인이 서명했습니다.

Brian Newman, un directeur de Colgate-Palmolive Co. (CL), a déclaré une acquisition non dérivée de 228 actions ordinaires le 01/10/2025 à un prix de 82,13 $ par action. Suite à la transaction, il détient directement 5 065 actions et indirectement 36 actions par le biais d'une fiducie familiale. Le dossier identifie le code d'achat A(1), et l'explication indique qu'il représente une partie du salaire annuel en espèces différé dans un compte d'unités d'actions dans le cadre du plan de rémunération différée pour les administrateurs non salariés de l'entreprise. Le Form 4 a été signé par un mandataire le 03/10/2025.

Brian Newman, ein Direktor der Colgate-Palmolive Co. (CL), meldete eine nicht derivativ erworbene Übernahme von 228 Stammaktien am 01.10.2025 zu einem Preis von 82,13 $ pro Aktie. Nach der Transaktion besitzt er direkt 5.065 Aktien und indirekt 36 Aktien durch einen Familientrust. Die Anmeldung identifiziert den Kaufcode A(1), und die Erläuterung besagt, dass dies einen Teil des jährlichen Bargeldentgelts darstellt, das in ein Aktien-Einheitenkonto im Rahmen des Deferred Compensation Plans for Non-Employee Directors des Unternehmens eingezogen wird. Das Formular 4 wurde am 03.10.2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Newman Brian

(Last) (First) (Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A(1) 228 A $82.13 5,065 D
Common Stock 36 I By Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
/s/ Kristine Hutchinson, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Colgate-Palmolive director Brian Newman report on Form 4?

He reported acquiring 228 shares of common stock on 10/01/2025 at $82.13 per share and now directly owns 5,065 shares.

Why was the purchase coded A(1) in the CL Form 4?

The filing explains code A(1) reflects a portion of the annual cash retainer deferred to a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.

Does Brian Newman hold any indirect Colgate-Palmolive shares?

Yes, the Form 4 shows 36 shares held indirectly through a family trust.

When was the Form 4 for this transaction signed and filed?

The form bears a signature by an attorney-in-fact on 10/03/2025 reflecting the reported 10/01/2025 transaction date.

Did the Form 4 disclose any derivative transactions for Brian Newman?

No. The Form 4 lists only a non-derivative acquisition of common stock and shows no derivative securities.
Colgate Palmolive Co

NYSE:CL

CL Rankings

CL Latest News

CL Latest SEC Filings

CL Stock Data

63.29B
806.85M
0.16%
86.07%
1.44%
Household & Personal Products
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
NEW YORK